News

uMotif experts to discuss the eCOA/ePRO market – what’s working, what’s wrong, and what patients need now
Press Release

uMotif experts to discuss the eCOA/ePRO market – what’s working, what’s wrong, and what patients need now

Read More
uMotif expands leadership team to support growth in US and EU markets
Press Release

uMotif expands leadership team to support growth in US and EU markets

Read More
uMotif and ClinOne unify eCOA / ePRO and eConsent
Press Release

uMotif and ClinOne unify eCOA / ePRO and eConsent

Read More
$25.5m of new investment from Athyrium Capital Management fund
Press Release

$25.5m of new investment from Athyrium Capital Management fund

Read More
Achieving more meaningful patient engagement in rare disease trials
Blog

Achieving more meaningful patient engagement in rare disease trials

Read More
AbbVie and uMotif support rheumatoid arthritis patients with BYOD approach
Press Release

AbbVie and uMotif support rheumatoid arthritis patients with BYOD approach

Read More
uMotif collaborates with The University of Manchester on body mapping tool
Press Release

uMotif collaborates with The University of Manchester on body mapping tool

Read More
uMotif evolves leadership team with appointment of Steve Rosenberg as CEO
Press Release

uMotif evolves leadership team with appointment of Steve Rosenberg as CEO

Read More
uMotif adds eClinical industry veteran Steve Rosenberg to board of directors
Press Release

uMotif adds eClinical industry veteran Steve Rosenberg to board of directors

Read More